nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—systemic scleroderma	0.195	0.783	CbGbCtD
Niacin—CYP2D6—Captopril—systemic scleroderma	0.0543	0.218	CbGbCtD
Niacin—HCAR2—connective tissue—systemic scleroderma	0.0177	0.128	CbGeAlD
Niacin—HCAR3—lung—systemic scleroderma	0.0161	0.117	CbGeAlD
Niacin—HCAR2—skin of body—systemic scleroderma	0.016	0.116	CbGeAlD
Niacin—HCAR2—lung—systemic scleroderma	0.0107	0.0772	CbGeAlD
Niacin—NNMT—connective tissue—systemic scleroderma	0.00996	0.072	CbGeAlD
Niacin—NNMT—smooth muscle tissue—systemic scleroderma	0.00911	0.0659	CbGeAlD
Niacin—NNMT—digestive system—systemic scleroderma	0.0072	0.052	CbGeAlD
Niacin—NNMT—tendon—systemic scleroderma	0.00685	0.0495	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—systemic scleroderma	0.00622	0.045	CbGeAlD
Niacin—NNMT—lung—systemic scleroderma	0.00601	0.0434	CbGeAlD
Niacin—SLC16A3—digestive system—systemic scleroderma	0.00491	0.0355	CbGeAlD
Niacin—SLC16A3—lung—systemic scleroderma	0.0041	0.0297	CbGeAlD
Niacin—SLC16A1—digestive system—systemic scleroderma	0.00299	0.0216	CbGeAlD
Niacin—SLC16A1—tendon—systemic scleroderma	0.00284	0.0205	CbGeAlD
Niacin—SLCO2B1—digestive system—systemic scleroderma	0.00257	0.0186	CbGeAlD
Niacin—SLC16A1—lung—systemic scleroderma	0.00249	0.018	CbGeAlD
Niacin—SLCO2B1—tendon—systemic scleroderma	0.00244	0.0177	CbGeAlD
Niacin—SLCO2B1—lung—systemic scleroderma	0.00215	0.0155	CbGeAlD
Niacin—SLC22A5—skin of body—systemic scleroderma	0.00213	0.0154	CbGeAlD
Niacin—SLC22A5—digestive system—systemic scleroderma	0.00171	0.0123	CbGeAlD
Niacin—SLC22A5—tendon—systemic scleroderma	0.00162	0.0117	CbGeAlD
Niacin—SLC22A5—lung—systemic scleroderma	0.00142	0.0103	CbGeAlD
Niacin—CYP2D6—digestive system—systemic scleroderma	0.0011	0.00795	CbGeAlD
Niacin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000513	0.000839	CcSEcCtD
Niacin—Cough—Lisinopril—systemic scleroderma	0.000511	0.000836	CcSEcCtD
Niacin—Muscular weakness—Prednisone—systemic scleroderma	0.00051	0.000833	CcSEcCtD
Niacin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000509	0.000831	CcSEcCtD
Niacin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000507	0.000829	CcSEcCtD
Niacin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000506	0.000827	CcSEcCtD
Niacin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000827	CcSEcCtD
Niacin—Tension—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000823	CcSEcCtD
Niacin—Insomnia—Leflunomide—systemic scleroderma	0.000503	0.000823	CcSEcCtD
Niacin—Abdominal distension—Prednisone—systemic scleroderma	0.000503	0.000822	CcSEcCtD
Niacin—Paraesthesia—Leflunomide—systemic scleroderma	0.0005	0.000817	CcSEcCtD
Niacin—Arthralgia—Lisinopril—systemic scleroderma	0.000499	0.000815	CcSEcCtD
Niacin—Myalgia—Lisinopril—systemic scleroderma	0.000499	0.000815	CcSEcCtD
Niacin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000815	CcSEcCtD
Niacin—Dyspnoea—Leflunomide—systemic scleroderma	0.000496	0.000811	CcSEcCtD
Niacin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000496	0.000811	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000495	0.00081	CcSEcCtD
Niacin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000494	0.000807	CcSEcCtD
Niacin—Dyspepsia—Leflunomide—systemic scleroderma	0.00049	0.000801	CcSEcCtD
Niacin—Vomiting—Mometasone—systemic scleroderma	0.000489	0.000799	CcSEcCtD
Niacin—Dry mouth—Lisinopril—systemic scleroderma	0.000488	0.000797	CcSEcCtD
Niacin—Rash—Mometasone—systemic scleroderma	0.000485	0.000792	CcSEcCtD
Niacin—Asthenia—Captopril—systemic scleroderma	0.000485	0.000792	CcSEcCtD
Niacin—Dermatitis—Mometasone—systemic scleroderma	0.000484	0.000791	CcSEcCtD
Niacin—Decreased appetite—Leflunomide—systemic scleroderma	0.000484	0.000791	CcSEcCtD
Niacin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000484	0.00079	CcSEcCtD
Niacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000482	0.000787	CcSEcCtD
Niacin—Headache—Mometasone—systemic scleroderma	0.000482	0.000787	CcSEcCtD
Niacin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000481	0.000785	CcSEcCtD
Niacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.00048	0.000785	CcSEcCtD
Niacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000478	0.000781	CcSEcCtD
Niacin—Oedema—Lisinopril—systemic scleroderma	0.000478	0.000781	CcSEcCtD
Niacin—Pruritus—Captopril—systemic scleroderma	0.000478	0.000781	CcSEcCtD
Niacin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000477	0.000779	CcSEcCtD
Niacin—Pain—Leflunomide—systemic scleroderma	0.000476	0.000778	CcSEcCtD
Niacin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000473	0.000773	CcSEcCtD
Niacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000472	0.000771	CcSEcCtD
Niacin—Shock—Lisinopril—systemic scleroderma	0.000471	0.000769	CcSEcCtD
Niacin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000767	CcSEcCtD
Niacin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000467	0.000764	CcSEcCtD
Niacin—Tachycardia—Lisinopril—systemic scleroderma	0.000467	0.000763	CcSEcCtD
Niacin—Abdominal pain—Azathioprine—systemic scleroderma	0.000466	0.000761	CcSEcCtD
Niacin—Body temperature increased—Azathioprine—systemic scleroderma	0.000466	0.000761	CcSEcCtD
Niacin—Skin disorder—Lisinopril—systemic scleroderma	0.000465	0.000759	CcSEcCtD
Niacin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000462	0.000755	CcSEcCtD
Niacin—Diarrhoea—Captopril—systemic scleroderma	0.000462	0.000755	CcSEcCtD
Niacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000462	0.000754	CcSEcCtD
Niacin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000461	0.000754	CcSEcCtD
Niacin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000752	CcSEcCtD
Niacin—Erectile dysfunction—Prednisone—systemic scleroderma	0.00046	0.000752	CcSEcCtD
Niacin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00046	0.000751	CcSEcCtD
Niacin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000458	0.000749	CcSEcCtD
Niacin—Nausea—Mometasone—systemic scleroderma	0.000457	0.000746	CcSEcCtD
Niacin—Anorexia—Lisinopril—systemic scleroderma	0.000456	0.000745	CcSEcCtD
Niacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000455	0.000744	CcSEcCtD
Niacin—Pain—Mycophenolic acid—systemic scleroderma	0.000454	0.000742	CcSEcCtD
Niacin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000741	CcSEcCtD
Niacin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000737	CcSEcCtD
Niacin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000732	CcSEcCtD
Niacin—Hypotension—Lisinopril—systemic scleroderma	0.000447	0.00073	CcSEcCtD
Niacin—Dizziness—Captopril—systemic scleroderma	0.000447	0.00073	CcSEcCtD
Niacin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000446	0.000729	CcSEcCtD
Niacin—Urticaria—Leflunomide—systemic scleroderma	0.000442	0.000722	CcSEcCtD
Niacin—Body temperature increased—Leflunomide—systemic scleroderma	0.00044	0.000719	CcSEcCtD
Niacin—Abdominal pain—Leflunomide—systemic scleroderma	0.00044	0.000719	CcSEcCtD
Niacin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000714	CcSEcCtD
Niacin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000714	CcSEcCtD
Niacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000436	0.000712	CcSEcCtD
Niacin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000434	0.00071	CcSEcCtD
Niacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000434	0.000709	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000709	CcSEcCtD
Niacin—Insomnia—Lisinopril—systemic scleroderma	0.000433	0.000707	CcSEcCtD
Niacin—Paraesthesia—Lisinopril—systemic scleroderma	0.000429	0.000702	CcSEcCtD
Niacin—Vomiting—Captopril—systemic scleroderma	0.000429	0.000702	CcSEcCtD
Niacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000699	CcSEcCtD
Niacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000426	0.000697	CcSEcCtD
Niacin—Rash—Captopril—systemic scleroderma	0.000426	0.000696	CcSEcCtD
Niacin—Dermatitis—Captopril—systemic scleroderma	0.000425	0.000695	CcSEcCtD
Niacin—Somnolence—Lisinopril—systemic scleroderma	0.000425	0.000695	CcSEcCtD
Niacin—Headache—Captopril—systemic scleroderma	0.000423	0.000691	CcSEcCtD
Niacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000421	0.000688	CcSEcCtD
Niacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00042	0.000686	CcSEcCtD
Niacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00042	0.000686	CcSEcCtD
Niacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000685	CcSEcCtD
Niacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000419	0.000685	CcSEcCtD
Niacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000416	0.000679	CcSEcCtD
Niacin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000413	0.000675	CcSEcCtD
Niacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000674	CcSEcCtD
Niacin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00041	0.00067	CcSEcCtD
Niacin—Pain—Lisinopril—systemic scleroderma	0.000409	0.000668	CcSEcCtD
Niacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000668	CcSEcCtD
Niacin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000665	CcSEcCtD
Niacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000662	CcSEcCtD
Niacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000403	0.000659	CcSEcCtD
Niacin—Haemoglobin—Prednisone—systemic scleroderma	0.000402	0.000657	CcSEcCtD
Niacin—Nausea—Captopril—systemic scleroderma	0.000401	0.000655	CcSEcCtD
Niacin—Haemorrhage—Prednisone—systemic scleroderma	0.0004	0.000653	CcSEcCtD
Niacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000399	0.000653	CcSEcCtD
Niacin—Asthenia—Leflunomide—systemic scleroderma	0.000399	0.000653	CcSEcCtD
Niacin—Pruritus—Leflunomide—systemic scleroderma	0.000394	0.000643	CcSEcCtD
Niacin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000392	0.00064	CcSEcCtD
Niacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000391	0.000639	CcSEcCtD
Niacin—Dizziness—Azathioprine—systemic scleroderma	0.00039	0.000637	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000384	0.000628	CcSEcCtD
Niacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000624	CcSEcCtD
Niacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000381	0.000622	CcSEcCtD
Niacin—Diarrhoea—Leflunomide—systemic scleroderma	0.000381	0.000622	CcSEcCtD
Niacin—Urticaria—Lisinopril—systemic scleroderma	0.00038	0.000621	CcSEcCtD
Niacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000379	0.000619	CcSEcCtD
Niacin—Body temperature increased—Lisinopril—systemic scleroderma	0.000378	0.000618	CcSEcCtD
Niacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000378	0.000618	CcSEcCtD
Niacin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.000615	CcSEcCtD
Niacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000376	0.000614	CcSEcCtD
Niacin—Vomiting—Azathioprine—systemic scleroderma	0.000375	0.000612	CcSEcCtD
Niacin—Eye disorder—Prednisone—systemic scleroderma	0.000374	0.00061	CcSEcCtD
Niacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00061	CcSEcCtD
Niacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000609	CcSEcCtD
Niacin—Rash—Azathioprine—systemic scleroderma	0.000372	0.000607	CcSEcCtD
Niacin—Dermatitis—Azathioprine—systemic scleroderma	0.000371	0.000607	CcSEcCtD
Niacin—Flushing—Prednisone—systemic scleroderma	0.000371	0.000606	CcSEcCtD
Niacin—Headache—Azathioprine—systemic scleroderma	0.000369	0.000603	CcSEcCtD
Niacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000603	CcSEcCtD
Niacin—Dizziness—Leflunomide—systemic scleroderma	0.000368	0.000601	CcSEcCtD
Niacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000364	0.000595	CcSEcCtD
Niacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000363	0.000594	CcSEcCtD
Niacin—Stomatitis—Methotrexate—systemic scleroderma	0.000363	0.000593	CcSEcCtD
Niacin—Angiopathy—Prednisone—systemic scleroderma	0.000363	0.000593	CcSEcCtD
Niacin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000591	CcSEcCtD
Niacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000586	CcSEcCtD
Niacin—Arrhythmia—Prednisone—systemic scleroderma	0.000357	0.000584	CcSEcCtD
Niacin—Sweating—Methotrexate—systemic scleroderma	0.000357	0.000583	CcSEcCtD
Niacin—Vomiting—Leflunomide—systemic scleroderma	0.000354	0.000578	CcSEcCtD
Niacin—Alopecia—Prednisone—systemic scleroderma	0.000353	0.000577	CcSEcCtD
Niacin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000352	0.000576	CcSEcCtD
Niacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000351	0.000574	CcSEcCtD
Niacin—Rash—Leflunomide—systemic scleroderma	0.000351	0.000573	CcSEcCtD
Niacin—Dermatitis—Leflunomide—systemic scleroderma	0.000351	0.000573	CcSEcCtD
Niacin—Nausea—Azathioprine—systemic scleroderma	0.00035	0.000572	CcSEcCtD
Niacin—Headache—Leflunomide—systemic scleroderma	0.000349	0.00057	CcSEcCtD
Niacin—Erythema—Prednisone—systemic scleroderma	0.000348	0.000569	CcSEcCtD
Niacin—Malnutrition—Prednisone—systemic scleroderma	0.000348	0.000569	CcSEcCtD
Niacin—Asthenia—Lisinopril—systemic scleroderma	0.000343	0.000561	CcSEcCtD
Niacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00056	CcSEcCtD
Niacin—Pruritus—Lisinopril—systemic scleroderma	0.000338	0.000553	CcSEcCtD
Niacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000338	0.000552	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—systemic scleroderma	0.000336	0.000549	CcSEcCtD
Niacin—Rash—Mycophenolic acid—systemic scleroderma	0.000335	0.000547	CcSEcCtD
Niacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000334	0.000547	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—systemic scleroderma	0.000334	0.000546	CcSEcCtD
Niacin—Hepatitis—Methotrexate—systemic scleroderma	0.000334	0.000546	CcSEcCtD
Niacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000544	CcSEcCtD
Niacin—Headache—Mycophenolic acid—systemic scleroderma	0.000333	0.000544	CcSEcCtD
Niacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000541	CcSEcCtD
Niacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000541	CcSEcCtD
Niacin—Nausea—Leflunomide—systemic scleroderma	0.000331	0.00054	CcSEcCtD
Niacin—Vision blurred—Prednisone—systemic scleroderma	0.000328	0.000536	CcSEcCtD
Niacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000327	0.000535	CcSEcCtD
Niacin—Visual impairment—Methotrexate—systemic scleroderma	0.000322	0.000526	CcSEcCtD
Niacin—Angioedema—Prednisone—systemic scleroderma	0.000318	0.00052	CcSEcCtD
Niacin—Dizziness—Lisinopril—systemic scleroderma	0.000316	0.000517	CcSEcCtD
Niacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000315	0.000515	CcSEcCtD
Niacin—Vertigo—Prednisone—systemic scleroderma	0.000313	0.000511	CcSEcCtD
Niacin—Eye disorder—Methotrexate—systemic scleroderma	0.000312	0.00051	CcSEcCtD
Niacin—Syncope—Prednisone—systemic scleroderma	0.000312	0.00051	CcSEcCtD
Niacin—Tinnitus—Methotrexate—systemic scleroderma	0.000312	0.000509	CcSEcCtD
Niacin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000504	CcSEcCtD
Niacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000306	0.0005	CcSEcCtD
Niacin—Vomiting—Lisinopril—systemic scleroderma	0.000304	0.000497	CcSEcCtD
Niacin—Angiopathy—Methotrexate—systemic scleroderma	0.000303	0.000495	CcSEcCtD
Niacin—Rash—Lisinopril—systemic scleroderma	0.000302	0.000493	CcSEcCtD
Niacin—Dermatitis—Lisinopril—systemic scleroderma	0.000301	0.000492	CcSEcCtD
Niacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000491	CcSEcCtD
Niacin—Chills—Methotrexate—systemic scleroderma	0.0003	0.00049	CcSEcCtD
Niacin—Headache—Lisinopril—systemic scleroderma	0.0003	0.00049	CcSEcCtD
Niacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000484	CcSEcCtD
Niacin—Myalgia—Prednisone—systemic scleroderma	0.000296	0.000484	CcSEcCtD
Niacin—Arthralgia—Prednisone—systemic scleroderma	0.000296	0.000484	CcSEcCtD
Niacin—Alopecia—Methotrexate—systemic scleroderma	0.000295	0.000482	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000294	0.000481	CcSEcCtD
Niacin—Erythema—Methotrexate—systemic scleroderma	0.000291	0.000475	CcSEcCtD
Niacin—Malnutrition—Methotrexate—systemic scleroderma	0.000291	0.000475	CcSEcCtD
Niacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000468	CcSEcCtD
Niacin—Nausea—Lisinopril—systemic scleroderma	0.000284	0.000464	CcSEcCtD
Niacin—Oedema—Prednisone—systemic scleroderma	0.000284	0.000464	CcSEcCtD
Niacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000284	0.000464	CcSEcCtD
Niacin—Shock—Prednisone—systemic scleroderma	0.000279	0.000457	CcSEcCtD
Niacin—Tachycardia—Prednisone—systemic scleroderma	0.000277	0.000453	CcSEcCtD
Niacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000453	CcSEcCtD
Niacin—Skin disorder—Prednisone—systemic scleroderma	0.000276	0.000451	CcSEcCtD
Niacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000275	0.000449	CcSEcCtD
Niacin—Vision blurred—Methotrexate—systemic scleroderma	0.000274	0.000448	CcSEcCtD
Niacin—Anorexia—Prednisone—systemic scleroderma	0.000271	0.000442	CcSEcCtD
Niacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000435	CcSEcCtD
Niacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000432	CcSEcCtD
Niacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000431	CcSEcCtD
Niacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000429	CcSEcCtD
Niacin—Vertigo—Methotrexate—systemic scleroderma	0.000261	0.000427	CcSEcCtD
Niacin—Leukopenia—Methotrexate—systemic scleroderma	0.00026	0.000425	CcSEcCtD
Niacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000259	0.000423	CcSEcCtD
Niacin—Insomnia—Prednisone—systemic scleroderma	0.000257	0.00042	CcSEcCtD
Niacin—Paraesthesia—Prednisone—systemic scleroderma	0.000255	0.000417	CcSEcCtD
Niacin—Cough—Methotrexate—systemic scleroderma	0.000254	0.000415	CcSEcCtD
Niacin—Dyspepsia—Prednisone—systemic scleroderma	0.00025	0.000409	CcSEcCtD
Niacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000407	CcSEcCtD
Niacin—Myalgia—Methotrexate—systemic scleroderma	0.000248	0.000405	CcSEcCtD
Niacin—Arthralgia—Methotrexate—systemic scleroderma	0.000248	0.000405	CcSEcCtD
Niacin—Decreased appetite—Prednisone—systemic scleroderma	0.000247	0.000403	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000246	0.000402	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000237	0.000388	CcSEcCtD
Niacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000232	0.00038	CcSEcCtD
Niacin—Skin disorder—Methotrexate—systemic scleroderma	0.000231	0.000377	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000229	0.000375	CcSEcCtD
Niacin—Anorexia—Methotrexate—systemic scleroderma	0.000226	0.00037	CcSEcCtD
Niacin—Urticaria—Prednisone—systemic scleroderma	0.000226	0.000369	CcSEcCtD
Niacin—Body temperature increased—Prednisone—systemic scleroderma	0.000225	0.000367	CcSEcCtD
Niacin—Abdominal pain—Prednisone—systemic scleroderma	0.000225	0.000367	CcSEcCtD
Niacin—Hypotension—Methotrexate—systemic scleroderma	0.000222	0.000362	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000216	0.000353	CcSEcCtD
Niacin—Insomnia—Methotrexate—systemic scleroderma	0.000215	0.000351	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—systemic scleroderma	0.000213	0.000348	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—systemic scleroderma	0.000212	0.000346	CcSEcCtD
Niacin—Somnolence—Methotrexate—systemic scleroderma	0.000211	0.000345	CcSEcCtD
Niacin—Hypersensitivity—Prednisone—systemic scleroderma	0.000209	0.000342	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000209	0.000341	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—systemic scleroderma	0.000206	0.000337	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000205	0.000335	CcSEcCtD
Niacin—Asthenia—Prednisone—systemic scleroderma	0.000204	0.000333	CcSEcCtD
Niacin—Pain—Methotrexate—systemic scleroderma	0.000203	0.000332	CcSEcCtD
Niacin—Pruritus—Prednisone—systemic scleroderma	0.000201	0.000328	CcSEcCtD
Niacin—Diarrhoea—Prednisone—systemic scleroderma	0.000194	0.000318	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000194	0.000317	CcSEcCtD
Niacin—Urticaria—Methotrexate—systemic scleroderma	0.000189	0.000308	CcSEcCtD
Niacin—Dizziness—Prednisone—systemic scleroderma	0.000188	0.000307	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000188	0.000307	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—systemic scleroderma	0.000188	0.000307	CcSEcCtD
Niacin—Vomiting—Prednisone—systemic scleroderma	0.000181	0.000295	CcSEcCtD
Niacin—Rash—Prednisone—systemic scleroderma	0.000179	0.000293	CcSEcCtD
Niacin—Dermatitis—Prednisone—systemic scleroderma	0.000179	0.000292	CcSEcCtD
Niacin—Headache—Prednisone—systemic scleroderma	0.000178	0.000291	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000175	0.000286	CcSEcCtD
Niacin—Asthenia—Methotrexate—systemic scleroderma	0.00017	0.000278	CcSEcCtD
Niacin—Nausea—Prednisone—systemic scleroderma	0.000169	0.000276	CcSEcCtD
Niacin—Pruritus—Methotrexate—systemic scleroderma	0.000168	0.000274	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—systemic scleroderma	0.000162	0.000265	CcSEcCtD
Niacin—Dizziness—Methotrexate—systemic scleroderma	0.000157	0.000256	CcSEcCtD
Niacin—Vomiting—Methotrexate—systemic scleroderma	0.000151	0.000247	CcSEcCtD
Niacin—Rash—Methotrexate—systemic scleroderma	0.00015	0.000245	CcSEcCtD
Niacin—Dermatitis—Methotrexate—systemic scleroderma	0.00015	0.000244	CcSEcCtD
Niacin—Headache—Methotrexate—systemic scleroderma	0.000149	0.000243	CcSEcCtD
Niacin—Nausea—Methotrexate—systemic scleroderma	0.000141	0.00023	CcSEcCtD
